MENU
PALI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Palisade Bio (PALI) Ownership - Who owns Palisade Bio?

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier... Show more

Profile

Industry
N/A
Address
4600 South Syracuse Street
Phone
+1 858 704-4900
Employees
14
Web
https://www.palisadebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
304.11M
P/E Ratio
14.58
Total Cash
132.63M
Projected Growth
N/A
Total Debt
211K
Revenue
N/A
Risk (Beta)
1.91
Dividend Yield
N/A
Total Cash/Share
0.76
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
PALI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds

Industry Biotechnology

Profile
Details
Industry
N/A
Address
4600 South Syracuse Street
Phone
+1 858 704-4900
Employees
14
Web
https://www.palisadebio.com